Trial intelligence / Profile preview

Frontline asciminib combinations in chronic phase CML

2018-002256-33Phase 2Active

Sponsor

Friedrich Schiller University Jena

Start

Mar 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1